| Date Filed | Type | Description |
| 06/15/2023 |
4
| WILSON TROY EDWARD (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Sold 27,000 shares
@ $3.4544, valued at
$93.3k
Granted 27,000 shares
@ $0 |
|
| 06/02/2023 |
4
| WILSON TROY EDWARD (President and CEO) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Disposed of 8,394 shares
@ $0
Acquired 8,394 shares
@ $0
Disposed of 41,318 shares
@ $0
Disposed of 212,500 shares
@ $0
Disposed of 300,000 shares
@ $0
Acquired 300,000 shares
@ $0
Disposed of 27,966 shares
@ $0 |
|
| 02/21/2023 |
4
| WILSON TROY EDWARD (President and CEO) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Disposed of 468,297 shares
@ $0
Disposed of 17,708 shares
@ $0
Disposed of 41,318 shares
@ $0
Acquired 41,318 shares
@ $0
Disposed of 1,084,300 shares
@ $0
Acquired 1,084,300 shares
@ $0
Disposed of 11,985 shares
@ $0
Granted 560,000 options to buy
@ $11.99, valued at
$6.7M
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| WILSON TROY EDWARD (Director) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 22,000 options to buy
@ $12.03, valued at
$264.7k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| WILSON TROY EDWARD (President and CEO) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 495,000 options to buy
@ $14.15, valued at
$7M
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| WILSON TROY EDWARD (President and CEO) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Disposed of 175,000 shares
@ $0
Granted 366,500 options to buy
@ $32.8, valued at
$12M
|
|
| 01/28/2021 |
SC 13G/A
| WILSON TROY EDWARD reports a 3.3% stake in Kura Oncology, Inc. |
| 12/28/2020 |
4
| WILSON TROY EDWARD (Director) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Disposed of 100,000 shares
@ $0
Acquired 100,000 shares
@ $0 |
|
| 12/02/2020 |
4
| WILSON TROY EDWARD (President and CEO) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Exercised 11,855 options to buy
@ $6.15, valued at
$72.9k
|
|
| 10/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2020 |
4
| WILSON TROY EDWARD (President and CEO) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Sold 17,926 shares
@ $28, valued at
$501.9k
Sold 485 shares
@ $28, valued at
$13.6k
Sold 98,490 shares
@ $28.824, valued at
$2.8M
Exercised 17,926 options to buy
@ $6.15, valued at
$110.2k
|
|
| 09/10/2020 |
4
| WILSON TROY EDWARD (President and CEO) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Sold 50,000 shares
@ $26, valued at
$1.3M
Sold 1,025 shares
@ $28, valued at
$28.7k
Sold 37,030 shares
@ $28, valued at
$1M
Exercised 37,030 options to buy
@ $6.15, valued at
$227.7k
|
|
| 08/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| WILSON TROY EDWARD (Director) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Converted 189,042 shares
@ $0
Converted 254,907 preferred shares
@ $0
Converted 35,374 preferred shares
@ $0
Converted 108,504 preferred shares
@ $0 |
|
| 06/15/2020 |
4
| WILSON TROY EDWARD (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Sold 25,245 shares
@ $9.97, valued at
$251.7k
|
|
| 06/11/2020 |
3
| WILSON TROY EDWARD (Director) has filed a Form 3 on Avidity Biosciences, Inc. |
| 06/11/2020 |
4
| WILSON TROY EDWARD (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Granted 25,748 shares
@ $0 |
|
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2020 |
4
| WILSON TROY EDWARD (President and CEO) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 393,950 options to buy
@ $11.86, valued at
$4.7M
|
|
| 01/31/2020 |
SC 13G/A
| WILSON TROY EDWARD reports a 5.8% stake in Kura Oncology, Inc. |
| 07/18/2019 |
4
| WILSON TROY EDWARD (Director) has filed a Form 4 on Zosano Pharma Corp|
Txns:
| Granted 1,500 options to buy
@ $2.34, valued at
$3.5k
|
|
| 06/12/2019 |
4
| WILSON TROY EDWARD (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Granted 19,423 shares
@ $0 |
|
| 01/30/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/24/2019 |
4
| WILSON TROY EDWARD (President and CEO) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 220,000 options to buy
@ $15.47, valued at
$3.4M
|
|
| 01/22/2019 |
5
| WILSON TROY EDWARD (President and CEO) has filed a Form 5 on Kura Oncology, Inc. |
| 11/09/2018 |
4
| WILSON TROY EDWARD (President and CEO) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Exercised 26,041 options to buy
@ $4.8, valued at
$125k
|
|
| 06/14/2018 |
4
| WILSON TROY EDWARD (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Granted 5,822 shares
@ $0 |
|
| 06/01/2018 |
4
| WILSON TROY EDWARD (Director) has filed a Form 4 on Zosano Pharma Corp|
Txns:
| Granted 25,000 options to buy
@ $4.24, valued at
$106k
|
|
|